Detailed Information on Publication Record
2022
Contrast-induced acute kidney injury and its contemporary prevention
SŮVA, Marek, Petr KALA, Martin POLOCZEK, Jan KAŇOVSKÝ, Roman ŠTÍPAL et. al.Basic information
Original name
Contrast-induced acute kidney injury and its contemporary prevention
Authors
SŮVA, Marek (203 Czech Republic, belonging to the institution), Petr KALA (203 Czech Republic, guarantor, belonging to the institution), Martin POLOCZEK (203 Czech Republic, belonging to the institution), Jan KAŇOVSKÝ (203 Czech Republic, belonging to the institution), Roman ŠTÍPAL (203 Czech Republic, belonging to the institution), Martin RADVAN (203 Czech Republic, belonging to the institution), Jiří HLÁSENSKÝ (203 Czech Republic, belonging to the institution), Martin HUDEC (203 Czech Republic, belonging to the institution), Vojtěch BRÁZDIL (203 Czech Republic, belonging to the institution) and Jitka ŘEHOŘOVÁ (203 Czech Republic)
Edition
Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2022, 2297-055X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.600
RIV identification code
RIV/00216224:14110/22:00128215
Organization unit
Faculty of Medicine
UT WoS
000899788400001
Keywords in English
PCI; nephrotoxicity; acute kidney injury; contrast-induced acute kidney injury; chronic renal insufficiency; prevention
Tags
International impact, Reviewed
Změněno: 23/1/2023 10:38, Mgr. Tereza Miškechová
Abstract
V originále
The complexity and application range of interventional and diagnostic procedures using contrast media (CM) have recently increased. This allows more patients to undergo procedures that involve CM administration. However, the intrinsic CM toxicity leads to the risk of contrast-induced acute kidney injury (CI-AKI). At present, effective therapy of CI-AKI is rather limited. Effective prevention of CI-AKI therefore becomes crucially important. This review presents an in-depth discussion of CI-AKI incidence, pathogenesis, risk prediction, current preventive strategies, and novel treatment possibilities. The review also discusses the difference between CI-AKI incidence following intraarterial and intravenous CM administration. Factors contributing to the development of CI-AKI are considered in conjunction with the mechanism of acute kidney damage. The need for ultimate risk estimation and the prediction of CI-AKI is stressed. Possibilities of CI-AKI prevention is evaluated within the spectrum of existing preventive measures aimed at reducing kidney injury. In particular, the review discusses intravenous hydration regimes and pre-treatment with statins and N-acetylcysteine. The review further focuses on emerging alternative imaging technologies, alternative intravascular diagnostic and interventional procedures, and new methods for intravenous hydration guidance; it discusses the applicability of those techniques in complex procedures and their feasibility in current practise. We put emphasis on contemporary interventional cardiology imaging methods, with a brief discussion of CI-AKI in non-vascular and non-cardiologic imaging and interventional studies.